My cases pending before Judge Bartle are the most advanced in the Zostavax litigation.
Englewood, NJ (PRWEB) August 03, 2018
On August 2, 2018 the JPML ordered that the Zostavax MDL be assigned to Judge Bartle for further proceedings. Mark Sadaka of Sadaka Associates, LLC has been litigating Zostavax injuries since 2011.
On July 26, 2018, Mr. Sadaka argued before the Judicial Panel on Multidistrict Litigation for the thousands of people injured by Zostavax, a vaccine given to adults to prevent shingles. Because there are so many people injured, Merck asked for all the cases to be heard in front of one court for pre-trial proceedings.
Sadaka Associates argued that the case should be consolidated in Philadelphia before Judge Bartle of the Eastern District of Pennsylvania. Mr. Sadaka's cases pending before Judge Bartle are the leading cases in the Zostavax litigation. Keeping the cases in Philadelphia will move them expeditiously to trial.
Mark Sadaka said “We are happy that the JPML selected Judge Bartle to handle the Zostavax MDL. My cases pending before Judge Bartle are the most advanced in the Zostavax litigation. Merck has already produced millions of pages of discovery and significant progress has been made in this litigation since I filed the first case in New Jersey in 2012. Judge Bartle has already decided two summary judgment motions and overheard multiple substantive motions over the course of the last two years. I look forward to developing all of these cases for trial and working with plaintiffs' attorneys from all over the country to see justice done.”
About Zostavax Lawsuits
Zostavax can cause shingles. Shingles may cause meningitis, encephalitis, stroke, and other brain injuries. Sadaka Associates has filed many shingles lawsuits on behalf of those seriously injured by Zostavax.
About Law Offices of Sadaka Associates, LLC
Law Offices of Sadaka Associates, LLC is a national firm with offices in New York City, New Jersey, and Baltimore. We have represented thousands of individuals harmed by dangerous drugs, medical devices, vaccines, exposure to toxic chemicals, and dangerous products.
Share article on social media or email: